Because of this, scientists have been looking for easier ways to help people control their blood pressure. One new solution ...

Researchers from places like the University of Edinburgh have been studying zilebesiran, and the early results are exciting.

Zilebesiran, an interfering RNA, administered every 3-6 months lowers blood pressure in patients with mild to moderate hypertension. For patients with mild to moderate hypertension, a single injection ...

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...

Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that giving people with high blood pressure an injection every six months can lead ...

ProvideGx, a company established by Premier in January to address generic drug shortages, will start with manufacturing a blood pressure medication that has been hard to obtain. The company, a ...

Sonali Gnanenthiran receives funding from NSW Health and the Medical Future Fund of Australia to conduct clinical trials to treat high blood pressure. Alta Schutte receives funding from the National ...